Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Surgical treatment of bone metastases E06-04

Surgical treatment of bone metastases E06-04 th Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007 12 World Conference on Lung Cancer as a unilateral pleural effusion, a pleural-based mass, an encompassing Education Session Abstracts rind of tumor, or as multiple pleural nodules. This information may be Session E01: Mesothelioma obtained from imaging studies or from observations of the surgeon at time of biopsy. The most common differential is between mesothelioma and adenocarcinoma, with pulmonary adenocarcinoma high on the list for pleural lesions. For this purpose, the author uses four positive mesothelial markers: calretinin (nuclear and cytoplasmic staining), E01-02 Mesothelioma, Mon, Sept 3, 16:00 – 17:30 cytokeratins 5/6 (cytoplasmic staining), WT-1 (nuclear staining), and State of the art mesothelioma diagnosis: a moving target D2-40 (membrane staining). In addition, two negative markers are employed: carcinoembryonic antigen (CEA) and TTF-1.5 Both of these Roggli, Victor L. markers have a high sensitivity for pulmonary adenocarcinomas, and Duke University Medical Center, Durham, NC, USA with respect to mesothelioma, the specificity of TTF-1 is 100%. Introduction Pulmonary adenocarcinomas are much lower on the differential The diagnosis of mesothelioma is a challenging one. There is no single diagnosis for peritoneal lesions, so a different set of markers http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arteriosclerosis Wolters Kluwer Health

Surgical treatment of bone metastases E06-04

Wedin, Rikard
Arteriosclerosis , Volume 2 – Aug 1, 2007
Download PDF
78 pages

Loading next page...
 
/lp/wolters-kluwer-health/surgical-treatment-of-bone-metastases-e06-04-01YDfMBn00

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0002-936X

Abstract

th Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007 12 World Conference on Lung Cancer as a unilateral pleural effusion, a pleural-based mass, an encompassing Education Session Abstracts rind of tumor, or as multiple pleural nodules. This information may be Session E01: Mesothelioma obtained from imaging studies or from observations of the surgeon at time of biopsy. The most common differential is between mesothelioma and adenocarcinoma, with pulmonary adenocarcinoma high on the list for pleural lesions. For this purpose, the author uses four positive mesothelial markers: calretinin (nuclear and cytoplasmic staining), E01-02 Mesothelioma, Mon, Sept 3, 16:00 – 17:30 cytokeratins 5/6 (cytoplasmic staining), WT-1 (nuclear staining), and State of the art mesothelioma diagnosis: a moving target D2-40 (membrane staining). In addition, two negative markers are employed: carcinoembryonic antigen (CEA) and TTF-1.5 Both of these Roggli, Victor L. markers have a high sensitivity for pulmonary adenocarcinomas, and Duke University Medical Center, Durham, NC, USA with respect to mesothelioma, the specificity of TTF-1 is 100%. Introduction Pulmonary adenocarcinomas are much lower on the differential The diagnosis of mesothelioma is a challenging one. There is no single diagnosis for peritoneal lesions, so a different set of markers

Journal

Arteriosclerosis – Wolters Kluwer Health

Published: Aug 1, 2007

There are no references for this article.